Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-484-9 | CAS number: 85536-04-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Genetic toxicity in vitro
Ames test (OECD 471, read across): negative with and without metabolic activation in S. typhimurium TA 1535, TA 1537, TA 100, TA 98, TA 102, E. coli WP2 uvrA, and E. coli WP2 uvrA pKM 101.
Chromosome aberration (OECD 473, read across): negative in Chinese hamster lung fibroblasts (V79) and in primary human peripheral lymphocytes with and without metabolic activation.
Gene mutation in mammalian cells (OECD 476, read across): negative in Chinese hamster lung fibroblasts (V79) with and without metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Summary of available data used for the endpoint assessment of the target substance
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- other: TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- other: Source: CAS 93803-87-3
- Conclusions:
- The read across approach is justified in the analogue justification. The target and source substances are considered unlikely to differ in their bacterial mutagenicity potential. Bacterial reverse mutation assays have been performed with the two structural analogue source substances 2-octyldodecyl isooctadecanoate (CAS 93803-87-3) and 2-octyldodecyl myristate (CAS 22766-83-2) both in the presence as well as in the absence of metabolic activation. All results obtained were negative, i.e. no gene mutation in bacteria was observed. Therefore, no mutagenic potential in bacteria is expected for target substance Fatty acids, C16-18 (even numbered), stearyl esters (CAS 85536-04-5).
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Summary of available data used for the endpoint assessment of the target substance
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- lymphocytes: cultured human peripheral lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- other: Source: CAS 93803-87-3
- Conclusions:
- The read across approach is justified in the analogue justification. The target and source substances are considered unlikely to differ in their genotoxic potential. In vitro mammalian cell chromosome aberration studies were performed with the source substances 2-octyldodecyl isooctadecanoate (CAS 93803-87-3) and oleyl oleate (CAS 3687-45-4) both in the presence and absence of metabolic activation. With both source substances no increase in the frequency of cells with chromosome aberrations was found in Chinese hamster lung fibroblast (V79) when tested up to precipitating concentrations. Therefore, no hazard with regard to chromosome aberration in mammalian cells is expected for target substance Fatty acids, C16-18 (even numbered), stearyl esters (CAS 85536-04-5).
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- precipitation at limit of water solubility at 100 µg/mL observed.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Source: CAS 3687-45-4
- Conclusions:
- The read across approach is justified in the analogue justification. The target and source substances are considered unlikely to differ in their genotoxic potential. An in vitro mammalian cell gene mutation study was performed with the source substance oleyl oleate (CAS 3687-45-4) both in the presence as well as in the absence of metabolic activation. No significant increase in mutation frequency was found in Chinese hamster lung fibroblast (V79) cells. Therefore, no mutagenic potential in mammalian cells is expected for target substance Fatty acids, C16-18 (even numbered), stearyl esters (CAS 85536-04-5).
Referenceopen allclose all
The bacterial reverse mutation assay with the source substance 2-octyldodecyl isooctadecanoate (CAS 93803-87-3) was selected as key result for reasons of structural similarity and data reliability. Additional data on mutagenicity in bacteria (Ames test) is given for the source substance 2-octyldodecyl myristate (CAS 22766-83-2): no mutagenicity was found in S. typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, and E. coli WP2 uvrA pKM 101 strains when tested at concentrations up to the limit value of 5 µL/plate with or without metabolic activation.
An in vitro mammalian chromosome aberration test with the source substance 2-octyldodecyl isooctadecanoate (CAS 93803-87-3) was selected as key result for reasons of structural similarity and data reliability. Additional data on in vitro cytogenicity is given for the source substance oleyl oleate (CAS 3687-45-4). No increase in the frequency of cells with chromosome aberrations was found in Chinese hamster lung fibroblast (V79) cells when tested up to precipitating concentrations of 100 µg/mL in the presence and absence of metabolic activation. The adequacy of test was determined vehicle, negative and positive controls, which were found to be valid.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Mode of Action Analysis / Human Relevance Framework
Not applicable
Additional information
Justification for read across
No data on the potential for genetic toxicity of Fatty acids, C16-18 (even numbered), stearyl esters (CAS 85536-04-5) are available. The assessment was therefore based on studies conducted with analogue substances as part of a read across approach, which is in accordance with Regulation (EC) No. 1907/2006, Annex XI, 1.5. For each specific endpoint the source substance(s) structurally closest to the target substance is/are chosen for read-across, with due regard to the requirements of adequacy and reliability of the available data. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Genetic toxicity (mutagenicity) in bacteria in vitro
CAS 93803-87-3
The in vitro genetic toxicity of 2-octyldodecyl isooctadecanoate (CAS 93803-87-3) was assessed in a bacterial reverse mutation study (Ames test), performed under GLP conditions according to OECD guideline 471(WoE, 1998). S. typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, and E. coli WP2 uvr A were exposed to the test substance at concentrations up to 1000 µg/plate. Precipitation was observed in the medium from 1000 µg/plate and above in all strain, with and without metabolic activation. The negative and positive controls were valid. The test substance did not induce reversions in the S. typhimurium strains or E. coli strain, with or without metabolic activation. Based on the study results, no mutagenicity in bacteria was found.
CAS 22766-83-2
The in vitro genetic toxicity of 2-octyldodecyl myristate (CAS 22766-83-2) was assessed in a bacterial reverse mutation study (Ames test), performed under GLP conditions according to OECD guideline 471 (WoE, 2007). The plate incorporation method was applied in the first experiment and the preincubation method in the second experiment, using S. typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, and E. coli WP2 uvrA pKM 101. All the strains were tested at concentrations up to the limit value of 5 µL/plate. The test substance did not induce an increase in reversions in the S. typhimurium and E.coli strains, with or without metabolic activation. No bacterial mutagenicity was observed, with and without metabolic activation. The positive and vehicle controls were valid. Based on the study results, no mutagenicity in bacteria was found.
Genetic toxicity (mutagenicity) in mammalian cells in vitro
CAS 3687-45-4
An in vitro mammalian cell gene mutation study was performed with oleyl oleate (CAS 3687-45-4) under GLP conditions according to OECD guideline 476 (key study, 1994). Two separate experiments were performed. Chinese hamster lung fibroblast (V79) cells were treated with oleyl oleate at concentrations of up to 100 µg/mL for 4 hours, with and without metabolic activation. After an expression time of 7 days in growth medium, cells were incubated for 9 or 12 days with 6 -thioguanine as selection agent for forward mutation at the HPRT locus. Precipitation was seen at concentrations of 100 µg/mL and higher, while no cytotoxicity was observed at any concentration level. The positive and negative controls were valid and within the range of historical control data. No significant increase in mutation frequency was observed, with and without metabolic activation. Based on the study results, no mutagenicity in mammalian cells was found.
Genetic toxicity (cytogenicity) in mammalian cells in vitro
CAS 3687-45-4
The potential of oleyl oleate (CAS 3687-45-4) to induce chromosomal aberrations was assessed using Chinese hamster lung fibroblast (V79) cells, in a GLP study performed according to OECD 473 (WoE, 1994). The V79-cells were exposed to oleyl oleate at concentrations up to 100 µg/mL, with and without metabolic activation (S9-mix). One experiment with duplicate replications was performed. A 4-hour treatment was performed without metabolic activation, using 10, 60 and 100 µg/mL concentration levels with 18-hour fixation time and a 100 µg/mL concentration level with a 28-hour fixation time. The treatment with metabolic activation was performed at concentrations of 10, 60 and 100 µg/mL with an 18-hour treatment time, and 18-hour fixation time and at 100 µg/mL with a 28-hour treatment time and 28-hour fixation time, respectively. The test material did not induce a statistically significant increase in the frequency of cells with chromosome aberrations, with or without metabolic activation. Precipitation was observed at concentrations from 100 µg/mL, while no cytotoxicity was noted at any concentration. The negative and positive controls were valid.
CAS 93803-87-3
The cytogenicity potential of 2-octyldodecyl isooctadecanoate (CAS 93803-87-3) was assessed in an in vitro mammalian chromosome aberration test in primary human lymphocytes, performed according to OECD Guideline 473 and under GLP conditions (WoE, 1998). Duplicate cultures of cultured human peripheral lymphocytes were evaluated for chromosome aberrations in the presence and absence of metabolic activation. In the first experiment, cells were incubated with test substance concentrations of 100, 333 and 1000 µg/mL for 24 hours with a 24-hour fixation time and at 1000 µg/mL for 48 hours with a 48-hour fixation time, in the absence of a metabolic activation system. The first experiment was also performed with cells exposed to 100, 333 and 1000 µg/mL for 3 hours with a 24-hour fixation time and at 1000 µg/mL for 3 hours with a 48-hour fixation time in the presence of metabolic activation. In the second experiment cells were incubated with 100, 333 and 1000 µg/mL for 24 hours followed by a 24-hour expression time, without metabolic activation. In the presence of metabolic activation cell were exposed to 100, 333 and 1000 µg/mL for 3 hours followed by a 24-hour expression time. No cytotoxicity was observed. At 1000 µg/mL, precipitation was observed in the culture medium. The vehicle and positive controls were valid. The test material did not induce a statistically significant increase in the frequency of cells with chromosome aberrations, with or without metabolic activation.
Overall conclusion for genetic toxicity
There are no available studies on the genetic toxicity of the target substance Fatty acids, C16-18 (even numbered), stearyl esters (CAS 85536-04-5).Therefore analogue read-across from source substances was applied from in vitro studies on cytogenicity, and in vitro studies on gene mutation in bacterial cells and mammalian cells. The results of the available in vitro studies were consistently negative. Based on the available data and following the analogue approach, no mutagenic or clastogenic potential in vitro is expected for Fatty acids, C16-18 (even numbered), stearyl esters (CAS 85536-04-5).
Justification for classification or non-classification
According to Article 13 of Regulation (EC) No. 1907/2006 "General Requirements for Generation of Information on Intrinsic Properties of substances", information on intrinsic properties of substances may be generated by means other than tests e.g. from information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI, "General rules for adaptation of this standard testing regime set out in Annexes VII to X” states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the analogue concept is applied to Fatty acids, C16-18 (even numbered), stearyl esters (CAS 85536-04-5), data will be generated from data for reference source substance(s) to avoid unnecessary animal testing. Additionally, once the analogue read-across concept is applied, substances will be classified and labelled on this basis.
Therefore, based on the analogue read-across approach, the available data on genetic toxicity do not meet the classification criteria according to Regulation (EC) 1272/2008 and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.